AzTrials
AzTrials

Depressive DisorderiDOVE2NCT03626103

Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents

A study testing + Brief ED Intervention (BI) and + Text in people with Depressive Disorder and Violence, run by Rhode Island Hospital at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this investigation is to test the efficacy of "iDOVE2" (a brief emergency department introductory session and longitudinal automated text-message depression prevention program for high-risk teens), and to determine the most potent and parsimonious combination of intervention components for preventing… Read more about this study

Who is it for?
Ages 13 to 17 years
Conditions the study is for
Depressive Disorder, Violence
What is being tested?
+ Brief ED Intervention (BI) and + Text
Could I receive a placebo?
No, everyone receives an active treatment
How many people
620 participants
Where
2 sitesUnited States
Study dates
1 Aug 2018to 28 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • English-speaking
  • presenting to the emergency department for routine care
  • reporting past-year physical violence (using a modified version of The Revised Conflict Tactics Scales (CTS-2) score ≥1), as identified on a brief screen administered in the ED
  • reporting past 2-week mild-to-moderate depressive symptoms (using Patient Health Questionnaire (PHQ-9) score 5-19), as identified on a brief screen administered in the ED
  • Accompanied by a parent/guardian who is present and able to consent
  • Possession of a cell phone with text-messaging capability

Who cannot join

  • Chief complaint of suicidality, psychosis, sexual assault, or child abuse
  • In police or child protective services' custody (as per state law)
  • Unable to assent
  • In need of emergency psychiatric care

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Yale New Haven Hospital

    New Haven, Connecticut, 06510

  • Rhode Island Hospital/Hasbro Children's Hospital

    Providence, Rhode Island, 02903

Other trials in United States

About this study

Official title: A Technology-Augmented Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Emergency Department Adolescents

The purpose of this investigation is to test the efficacy of "iDOVE2" (a brief emergency department introductory session and longitudinal automated text-message depression prevention program for high-risk teens), and to determine the most potent and parsimonious combination of intervention components for preventing peer violence and depressive symptoms among at-risk youth.

Read the detailed description

Peer violence and depressive symptoms have mutual, reinforcing negative impacts on teens' emotional and behavioral regulation strategies.

The emergency department (ED) is the primary source of care for many high-risk teens. It provides an opportunity to initiate preventive interventions, to complement existing mental health treatment or to stand alone for those who may lack access to formal care. Personalized text-message interventions are accessible, feasible, and may be effective with these adolescents.

The purpose of this study is to expand on the PI's pilot randomized controlled trial (RCT) of iDOVE (K23 MH095866; PI: Ranney) by testing the efficacy of "iDOVE2" (a brief emergency department introductory session and longitudinal automated text-message depression prevention program for high-risk teens). The investigators will use a 2x2 factorial design to determine the most potent and parsimonious combination of intervention components for preventing peer violence and depressive symptoms among at-risk youth.

Participants will be identified in the course of usual clinical care in the ED. If eligible, parents will be consented and participants assented. Participants will complete a baseline assessment and will be randomized to one of four groups: Brief ED Intervention (BI) + Text; BI + No Text; No BI + Text; or No BI + No Text. Youth in the Text arm who show no signal of improvement at 7 days, per daily self-reported mood ratings, will be re-randomized to additional "LiveText" (once-weekly real-time micro-counseling via text) or to continue with standard, automated Text intervention curriculum.

At baseline and follow-ups at 2 months, 4 months, and 8 months, participants will complete assessments on depressive symptoms, violence, cognitive/behavioral skill-sets, and resource utilization.

Being tested
+ Brief ED Intervention (BI), + Text
Keywords
depression, violence, emergency department, mhealth, text message
Medical subject headings
Depressive Disorder, Depression, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • + Brief ED Intervention (BI)Behavioural

    Brief ED Intervention (BI): A 20-minute Motivational Interviewing- and Cognitive Behavioral Therapy-based in-Emergency Department session delivered by a bachelors'-level Research Assistant

  • + TextBehavioural

    Text: 8 weeks of an automated, tailored, two-way text-message curriculum started after the ED visit, which reinforces cognitive reappraisal, emotional regulation, and self-efficacy skills. Those that do not show improvement in mood after 7 days will be randomized into LiveText.

Study groups in NCT03626103
Study groupRoleWhat they receive
+ Brief ED Intervention (BI), + TextExperimentalParticipants receive both the Brief ED Intervention component (a 20-minute Motivational Interviewing- and Cognitive Behavioral Therapy-based in-Emergency Department session delivered by a bachelors'-level Research Assistant) and the Text Message Intervention component (8 weeks of an automated, tailored, two-way text-message curriculum started after the ED visit, which reinforces cognitive reappraisal, emotional regulation, and self-efficacy skills).
Receives: Behavioral: + Brief ED Intervention (BI); Behavioral: + Text
+ Brief ED Intervention (BI), no TextExperimentalParticipants receive the Brief ED Intervention component only (which is a 20-minute Motivational Interviewing- and Cognitive Behavioral Therapy-based in-Emergency Department session delivered by a bachelors'-level Research Assistant).
Receives: Behavioral: + Brief ED Intervention (BI)
No Brief ED Intervention (BI), + TextExperimentalParticipants receive the Text Message Intervention component only (8 weeks of an automated, tailored, two-way text-message curriculum started after the ED visit, which reinforces cognitive reappraisal, emotional regulation, and self-efficacy skills). Participants receive a brochure containing online and community resources for violence and depression prevention instead of the Brief ED Intervention component.
Receives: Behavioral: + Text
No Brief ED Intervention (BI), no TextNo interventionParticipants receive neither the Brief ED Intervention component, nor the Text Message Intervention component. Participants receive a brochure containing online and community resources for violence and depression prevention, instead of the Brief ED Intervention component.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Conflict Tactics Scale-2, physical subset (CTS-2)

    Change from enrollment physical peer violence (score is summed, range 0 - 56)

    Measured: Enrollment, 2 months post-enrollment, 4 months post-enrollment, 8 months post-enrollment

  2. Center for Epidemiologic Studies Depression Scale Revised (CESD-R)

    Change from enrollment depressive symptoms (score is summed based on symptom group, range 0 - 80)

    Measured: Enrollment, 2 months post-enrollment, 4 months post-enrollment, 8 months post-enrollment

Secondary outcomes (4)
  1. Change in ED Visits for Assault-Related Injury

    Review of hospital system-wide Electronic Medical Record and state-wide Health Information Exchange to identify ED visits for peer assault

    Measured: 12 months before enrollment and 12 months after enrollment

  2. Conflict in Adolescent Dating Relationships Inventory, physical subset (CADRI)

    Change from enrollment other forms of peer violence (dating relationships)

    Measured: Enrollment, 2 months post-enrollment, 4 months post-enrollment, 8 months post-enrollment

  3. Illinois Bully Scale (IBS)

    Change from enrollment other forms of peer violence (bullying)

    Measured: Enrollment, 2 months post-enrollment, 4 months post-enrollment, 8 months post-enrollment

  4. Student School Survey

    Change from enrollment other forms of peer violence (bullying)

    Measured: Enrollment, 2 months post-enrollment, 4 months post-enrollment, 8 months post-enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Aug 2018
  2. Study start1 Aug 2018
  3. Primary completion28 Feb 2025
  4. Study completion28 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
620 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03626103
Sponsor's protocol ID
R01HD093655
Other IDs
R01HD093655
Acronym
iDOVE2
Status last verified
Apr 2026
First submitted
23 Jul 2018
Last updated
29 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing + Brief ED Intervention (BI) and + Text in people with Depressive Disorder and Violence, run by Rhode Island Hospital at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Conflict Tactics Scale-2, physical subset (CTS-2) (time frame: Enrollment, 2 months post-enrollment, 4 months post-enrollment, 8 months post-enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in